التفاصيل البيبلوغرافية
| العنوان: |
712 IMPORT-201 (IMP-MEL): a phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist (PORT-2) and pembrolizumab for advanced melanoma and non-small cell lung cancer (NSCLC) |
| المؤلفون: |
Coupe, Nicholas, Pinato, David J, Fairchild, Justin, Poe, Russell, Browne, Carri, Innaimo, Steven, Thompson, David, Gileadi, Uzi, Santo, Carmela De, Kramer, Robert, Walters, Ian, Middleton, Mark R |
| المصدر: |
Regular and Young Investigator Award Abstracts |
| بيانات النشر: |
BMJ Publishing Group Ltd |
| سنة النشر: |
2023 |
| نوع الوثيقة: |
conference object |
| اللغة: |
unknown |
| DOI: |
10.1136/jitc-2023-sitc2023.0712 |
| DOI: |
10.1136/jitc-2023-SITC2023.0712 |
| الإتاحة: |
https://doi.org/10.1136/jitc-2023-sitc2023.0712Test |
| حقوق: |
http://creativecommons.org/licenses/by-nc/4.0Test/ |
| رقم الانضمام: |
edsbas.ED05CC21 |
| قاعدة البيانات: |
BASE |
